AstraZeneca
at elevate phase trial lower incidences of any grade atrial fibrillation flutter solid safety overall | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
June 2021
Slide
28 of 40
Related slides by other companies
Immatics
Investor Presentation
November 2023
tolerability data cohort gen | Immatics
Compass Therapeutics
Investor Presentation
February 2023
phase safety data hei as observed in patient | Compass Therapeutics
Compass Therapeutics
Investor Presentation
May 2023
phase safety data | Compass Therapeutics
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io